233 related articles for article (PubMed ID: 37795100)
21. Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.
Gennip ACEV; Broers NJH; Meulen KJT; Canaud B; Christiaans MHL; Cornelis T; Gelens MACJ; Hermans MMH; Konings CJAM; Net JBV; Sande FMV; Schalkwijk CG; Stifft F; Wirtz JJJM; Kooman JP; Martens RJH
PLoS One; 2019; 14(9):e0222547. PubMed ID: 31518378
[TBL] [Abstract][Full Text] [Related]
22. [Uremic Toxins: how can we improve the removal today?].
Teatini U; Romei Longhena G
G Ital Nefrol; 2017 Sep; 34(5):89-101. PubMed ID: 28963830
[TBL] [Abstract][Full Text] [Related]
23. High-permeability alternatives to current dialyzers performing both high-flux hemodialysis and postdilution online hemodiafiltration.
Maduell F; Rodas L; Broseta JJ; Gómez M; Xipell Font M; Molina A; Montagud-Marrahi E; Guillén E; Arias-Guillén M; Fontseré N; Vera Rivera M; Rico N
Artif Organs; 2019 Oct; 43(10):1014-1021. PubMed ID: 31038748
[TBL] [Abstract][Full Text] [Related]
24. p53 impairs endothelial function by transcriptionally repressing Kruppel-Like Factor 2.
Kumar A; Kim CS; Hoffman TA; Naqvi A; Dericco J; Jung SB; Lin Z; Jain MK; Irani K
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):133-41. PubMed ID: 20947822
[TBL] [Abstract][Full Text] [Related]
25. Randomized controlled trial of medium cut-off versus high-flux dialyzers on quality of life outcomes in maintenance hemodialysis patients.
Lim JH; Park Y; Yook JM; Choi SY; Jung HY; Choi JY; Park SH; Kim CD; Kim YL; Cho JH
Sci Rep; 2020 May; 10(1):7780. PubMed ID: 32385307
[TBL] [Abstract][Full Text] [Related]
26. Cytokines and chemokines systemic levels are related to dialysis adequacy and creatinine clearance in patients with end-stage renal disease undergoing hemodialysis.
Silva RE; Santos EC; Justino PBI; Santos MP; Galdino G; Gonçalves RV; Novaes RD
Int Immunopharmacol; 2021 Nov; 100():108154. PubMed ID: 34555645
[TBL] [Abstract][Full Text] [Related]
27. Acute Effects of Hemodiafiltration Versus Conventional Hemodialysis on Endothelial Function and Inflammation: A Randomized Crossover Study.
Jia P; Jin W; Teng J; Zhang H; Zou J; Liu Z; Shen B; Cao X; Ding X
Medicine (Baltimore); 2016 Apr; 95(16):e3440. PubMed ID: 27100440
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of therapeutic effects between medium cut-off and high flux dialyzers using metabolomics and proteomics: exploratory, prospective study in hemodialysis.
Kim HJ; Seong EY; Lee W; Kim S; Ahn HS; Yeom J; Kim K; Kwon CH; Song SH
Sci Rep; 2021 Aug; 11(1):17335. PubMed ID: 34462546
[TBL] [Abstract][Full Text] [Related]
29. Suberanilohydroxamic Acid as a Pharmacological Kruppel-Like Factor 2 Activator That Represses Vascular Inflammation and Atherosclerosis.
Xu Y; Xu S; Liu P; Koroleva M; Zhang S; Si S; Jin ZG
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29191808
[TBL] [Abstract][Full Text] [Related]
30. Expanded hemodialysis: a new concept of renal replacement therapy.
Jonny J; Teressa M
J Investig Med; 2023 Jan; 71(1):38-41. PubMed ID: 36316065
[TBL] [Abstract][Full Text] [Related]
31. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction.
Xu S; Liu Y; Ding Y; Luo S; Zheng X; Wu X; Liu Z; Ilyas I; Chen S; Han S; Little PJ; Jain MK; Weng J
Signal Transduct Target Ther; 2021 Jul; 6(1):266. PubMed ID: 34253708
[TBL] [Abstract][Full Text] [Related]
32. Skin Blood Flow and Vascular Endothelium Function in Uremia.
Smogorzewski MJ
J Ren Nutr; 2017 Nov; 27(6):465-469. PubMed ID: 29056167
[TBL] [Abstract][Full Text] [Related]
33. Medium Cut-Off Dialysis Membrane and Dietary Fiber Effects on Inflammation and Protein-Bound Uremic Toxins: A Systematic Review and Protocol for an Interventional Study.
Herič T; Vivoda T; Bogataj Š; Pajek J
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33805509
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin counteracts high glucose-induced Krüppel-like factor 2 suppression in human umbilical vein endothelial cells.
Liu YS; Xu DL; Huang ZW; Hao L; Wang X; Lu QH
Postgrad Med; 2015 Jun; 127(5):446-54. PubMed ID: 25927862
[TBL] [Abstract][Full Text] [Related]
35. Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.
Vaziri ND; Navab K; Gollapudi P; Moradi H; Pahl MV; Barton CH; Fogelman AM; Navab M
J Natl Med Assoc; 2011 Jun; 103(6):524-33. PubMed ID: 21830637
[TBL] [Abstract][Full Text] [Related]
36. Association of circulating MtDNA with CVD in hemodialysis patients and in vitro effect of exogenous MtDNA on cardiac microvascular inflammation.
Fan Z; Feng Y; Zang L; Guo Y; Zhong XY
BMC Cardiovasc Disord; 2023 Feb; 23(1):74. PubMed ID: 36755219
[TBL] [Abstract][Full Text] [Related]
37. Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins.
Ciceri P; Cozzolino M
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073439
[TBL] [Abstract][Full Text] [Related]
38. Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2.
Li W; Wang C; Zhang D; Zeng K; Xiao S; Chen F; Luo J
Aging (Albany NY); 2021 May; 13(9):12996-13005. PubMed ID: 33946046
[TBL] [Abstract][Full Text] [Related]
39. Role of Krüppel-like factor-2 in kidney disease.
Zhong F; Lee K; He JC
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():53-56. PubMed ID: 30298668
[TBL] [Abstract][Full Text] [Related]
40. The Rationale for Expanded Hemodialysis Therapy (HDx).
Hutchison CA; Wolley M
Contrib Nephrol; 2017; 191():142-152. PubMed ID: 28910797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
